Cytek Biosciences, Inc.
Cytek Biosciences, Inc. (CTKB) Stock Overview
Explore Cytek Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
467.4M
P/E Ratio
-41.57
EPS (TTM)
$-0.09
ROE
-0.03%
CTKB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cytek Biosciences, Inc. (CTKB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.83.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -41.57 and a market capitalization of 467.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.